Clare Khan
Directeur/Membre du Conseil chez SOLID BIOSCIENCES INC.
Fortune : 9 086 $ au 31/05/2024
Postes actifs de Clare Khan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Membre du Conseil | 02/03/2021 | - |
| Independent Dir/Board Member | 02/03/2021 | - | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | 01/10/2019 | - |
| Corporate Officer/Principal | 01/10/2018 | 01/10/2019 | |
| Clare Kahn Pharma Consulting LLC | President | 01/06/2016 | - |
Historique de carrière de Clare Khan
Anciens postes connus de Clare Khan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/06/2010 | 01/06/2016 |
| GSK PLC | Conseiller Juridique Général | 01/01/1999 | 01/01/2010 |
| University of Pennsylvania | Corporate Officer/Principal | 01/01/1981 | 01/01/1985 |
Formation de Clare Khan
| Royal Postgraduate Medical School | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| 2 | |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SOLID BIOSCIENCES INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Health Technology |
| Clare Kahn Pharma Consulting LLC |
- Bourse
- Insiders
- Clare Khan
- Expérience
